PDS Biotechnology Schedules 2026 Annual Meeting and Sets Deadline for Stockholder Proposals

PDS Biotechnology Corporation announced that its Board of Directors has scheduled the 2026 Annual Meeting of Stockholders for August 10, 2026. Because this date is more than 30 days from the anniversary of the 2025 Annual Meeting, the company has established a new deadline for stockholder proposals. Stockholders wishing to submit proposals for inclusion in the company's proxy materials for the 2026 Annual Meeting must do so by June 25, 2026. These proposals must comply with Rule 14a-8 under the Securities Exchange Act of 1934 and other applicable SEC regulations. Detailed information regarding the meeting will be provided in a forthcoming Definitive Proxy Statement on Schedule 14A. The filing also confirms the company's address in Princeton, New Jersey, and its listing on the Nasdaq Capital Market under the symbol PDSB.